FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.
about
Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancerEmerging data on androgen receptor splice variants in prostate cancerAndrogen receptor splice variants determine taxane sensitivity in prostate cancer.Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.Constitutive activity of the androgen receptor.Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants.Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.Mechanisms of acquired resistance to androgen receptor targeting drugs in castration-resistant prostate cancer.Androgen receptor splice variants in the era of enzalutamide and abiraterone.Are androgen receptor variants a substitute for the full-length receptor?Metastatic castration-resistant prostate cancer: targeting the mechanisms of resistance to abiraterone acetate and enzalutamide.Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting.Drug discovery in advanced prostate cancer: translating biology into therapy.Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.Milk disrupts p53 and DNMT1, the guardians of the genome: implications for acne vulgaris and prostate cancer.CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasionTargeting constitutively active androgen receptor splice variants in castration resistant prostate cancerTargeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities.
P2860
Q26858922-7AD22C53-3075-47CD-9FCA-399516BE5102Q28077830-C96C57E8-6DFC-4A60-8D65-1955F73C16B8Q30577613-147027E2-6149-46E1-A043-81BE6403A339Q33775726-8ABB3F52-029C-4672-B02F-A248D752F4D8Q34775572-D8B03AB4-7460-483E-B2C0-1E1F83BE8A3DQ34951635-68C8A67E-6214-4B41-A404-4EF0E6279414Q35181646-38A05DFF-CF90-47B5-8114-FB02D7B8378FQ36312095-C6B7E4FF-96F9-45C2-B194-399A9594B5CDQ37737611-4D7BE4ED-AFC8-488D-8438-4BCFE575E308Q38220073-7F82B128-F129-4A01-8C36-87CC6573C0E0Q38232413-F2471856-F7DA-41B0-AE95-FC456A9DB2E1Q38350089-90066787-3ACA-442A-9D69-0C45ACEC8BEEQ38541877-5B16F40D-D5C2-433B-87A6-604D5B1ECB28Q38835693-FD9FEE68-B810-4C63-BC2A-28563E979516Q38839110-ACE460D5-8E6D-4E5E-B16B-CE3294356DB9Q38965002-3B0A0BE3-D45B-4F2E-A6A7-CF0E6B81AA2AQ41396848-82B4A165-6671-40DE-BF01-9D48F788F407Q41593121-746C7B8E-5D39-4C63-BFBC-1805549F76F7Q42182625-7A5C7A6F-A352-4EF2-AC40-F0F78F88135DQ52683959-057E4A63-E7DC-445D-B59C-4325D1493565
P2860
FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FOXO1 binds to the TAU5 motif ...... ogen receptor splice variants.
@en
FOXO1 binds to the TAU5 motif ...... ogen receptor splice variants.
@nl
type
label
FOXO1 binds to the TAU5 motif ...... ogen receptor splice variants.
@en
FOXO1 binds to the TAU5 motif ...... ogen receptor splice variants.
@nl
prefLabel
FOXO1 binds to the TAU5 motif ...... ogen receptor splice variants.
@en
FOXO1 binds to the TAU5 motif ...... ogen receptor splice variants.
@nl
P2093
P2860
P356
P1433
P1476
FOXO1 binds to the TAU5 motif ...... ogen receptor splice variants.
@en
P2093
Haojie Huang
James Angstman
Laura R Bohrer
Lucas J Brand
Scott M Dehm
Yunqian Pan
P2860
P304
P356
10.1002/PROS.22649
P50
P577
2013-02-06T00:00:00Z